Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terence Partridge

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Skeletal Muscle|May 20, 2015
Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasiaWilliam Duddy, Stephanie Duguez, Helen Johnston, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 19, 2018
Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model NeonatesKenji Rowel Q Lim, Yusuke Echigoya, Tetsuya Nagata, et al.
Cellular and Molecular Life Sciences : CMLS|January 25, 2013
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretionStephanie Duguez, William Duddy, Helen Johnston, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense deliveryYoshitsugu Aoki, Toshifumi Yokota, Tetsuya Nagata, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2007
Lack of myostatin results in excessive muscle growth but impaired force generationHelge Amthor, Raymond Macharia, Roberto Navarrete, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 26, 2019
Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onsetJesse M Damsker, Michaelyn R Cornish, Priya Kanneboyina, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2009
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activityHelge Amthor, Anthony Otto, Adeline Vulin, et al.
Plos One|June 25, 2010
Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular DystrophyAlfredo D Guerron, Rashmi Rawat, Arpana Sali, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Skeletal Muscle|May 20, 2015
Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasiaWilliam Duddy, Stephanie Duguez, Helen Johnston, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 19, 2018
Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model NeonatesKenji Rowel Q Lim, Yusuke Echigoya, Tetsuya Nagata, et al.
Cellular and Molecular Life Sciences : CMLS|January 25, 2013
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretionStephanie Duguez, William Duddy, Helen Johnston, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense deliveryYoshitsugu Aoki, Toshifumi Yokota, Tetsuya Nagata, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2007
Lack of myostatin results in excessive muscle growth but impaired force generationHelge Amthor, Raymond Macharia, Roberto Navarrete, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 26, 2019
Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onsetJesse M Damsker, Michaelyn R Cornish, Priya Kanneboyina, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2009
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activityHelge Amthor, Anthony Otto, Adeline Vulin, et al.
Plos One|June 25, 2010
Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular DystrophyAlfredo D Guerron, Rashmi Rawat, Arpana Sali, et al.
Pageof 3